Arshad, H.M.E. et al. 2025. Survival impact and safety comparison of pirfenidone and nintedanib for idiopathic pulmonary fibrosis: A meta-analysis. Sarcoidosis, Vasculitis and Diffuse Lung Diseases. 42, 3 (Sep. 2025), 16432. DOI:https://doi.org/10.36141/svdld.v42i3.16432.